2022 International Congress Archives - Page 80 of 153

Intraoperative microelectrode recodings reveal functional structure of Globus Pallidus pars interna in dystonic patients

A. Kaymak, M. Vissani, S. Rinaldo, R. Eleopra, L. Romito, A. Mazzoni (Pisa, Italy)
Intraoperative quantification of MDS-UPDRS tremor measurements using 3D accelerometry

A. Smid, J. Elting, J. van Dijk, E. Otten, D. Oterdoom, K. Tamasi, T. Heida, T. van Laar, G. Drost (Groningen, Netherlands)
Investigating genetic risk factors for Lewy body dementia

J. Lee, S. Jo, S. Lee, MS. Kim, SJ. Chung (Seoul, Republic of Korea)
Investigating inflammatory mechanisms in iPSC-derived LRRK2 microglia

K. Badanjak, P. Mulica, P. Seibler, M. Ali, C. Venegas, S. Pereira, C. Klein, P. Antony, E. Glaab, A. Grünewald (Esch-Sur-Alzette, Luxembourg)
Investigating the use of DAT-SPECT as an enrichment biomarker to determine eligibility for the phase 2 clinical trial PASADENA

T. Kustermann, S. Holiga, S. Zanigni, H. Svoboda, T. Nikolcheva, G. Pagano, K. Taylor (Basel, Switzerland)
Investigation of Modifiers of β-Glucocerebrosidase in Cell Models of Parkinson’s Disease

A. Wernick, J. Evans, G. Virdi, M. Choi, D. Athauda, Z. Zanjani Shadman, H. Plun-Favreau, S. Wray, S. Gandhi (London, United Kingdom)
Investigative Study of Local Field Potential (LFP) changes during acute and chronic Deep Brain Stimulation (DBS) in Parkinson’s Disease (PD) patients

G. Varga, V. Rayudu, J. Abraham (Austin, USA)
Invisible DBS-lead fixation using a patient-specific burr-hole cover

L. Stieglitz (Zurich, Switzerland)
Involving people with lived experience of Parkinson’s in trial design: the EJS ACT-PD initiative

M-L. Zeissler, N. Bakshi, M. Bartlett, A. Batla, D. Byrom, R. Chapman, E. Deeson, R. Ellis-Doyle, C. Gonzales-Robles, A. Jewell, H. Matthews, L. Miller, G. Mills, L. Mooney, A. Morgan, J. Rudiger, D. Salathiel, P. Scurfield, C. Siu, S. Whipps, S. Wonnacott, T. Foltynie, C. Carroll, K. Mcfarthing (Plymouth, United Kingdom)
IPX203 dose conversion from immediate-release carbidopa-levodopa, in Parkinson’s disease patients with motor fluctuations.

R. Hauser, A. Espay, W. Ondo, B. Safirstein, H. Moore, R. Kumar, G. Banisadr, S. Fisher (Tampa, USA)